Nov. 26th, 10am local time in NYC, NASDAQ has featured Eukarÿs on its giant screen in Times Square, for having both:
1 – won the 2025 Grand Prize of Biotools Innovator, the only startup accelerator dedicated to Life Sciences Tools, after an extremely selective process, which had started early 2025 with 440 candidates from 43 countries,
2 – been selected by BARDA as member of the Vanguard acceleration program, focused on enabling technologies identified as critical for responsiveness in case of health crisis like pandemics or bioterrorist attacks.
